• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Focus nets clearance for CardioMatch

Article

Focus Medical has received Food and Drug Administration 510(k) clearance for CardioMatch, a 3-D image analysis software program designed to improve the specificity of a myocardial perfusion study. The Belmont, CA-based company is also in final

Focus Medical has received Food and Drug Administration 510(k) clearance for CardioMatch, a 3-D image analysis software program designed to improve the specificity of a myocardial perfusion study. The Belmont, CA-based company is also in final negotiations with a major medical university and hospital group in Northern California to perform a large clinical validation study using CardioMatch.

CardioMatch has been cleared as a cardiac diagnostic software program to quantitatively analyze myocardial perfusion in patients injected with Cardiolite or thallium-201 following a rest/stress SPECT acquisition protocol. The company unveiled CardioMatch at the annual meeting of the Society of Nuclear Medicine in June (SCAN Special Report 6/97).

Focus plans to continue to pursue new applications for its image analysis technology. The firm expects to file a 510(k) application in the fourth quarter for PneumoMatch, which is targeted at the early detection, quantitation, and 3-D visualization of pulmonary embolism. Additional neurological and oncologic applications are also on the drawing board.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.